CVRdatabase
Menu

BactiQuant A/S

Public limited companyCVR 24231712BirkerødActive

BactiQuant A/S is a public limited company, based in Birkerød, active in research and experimental development on natural sciences and engineering, founded in 1999. The company made a loss in both 2024 and 2025, most recently DKK 13.8m. With 19 employees, the company is about 4 times larger than the industry median. Equity grew to DKK 17.3m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 8.3m+15.9% vs. 2024
Net profit−DKK 13.8m−0.8% vs. 2024
EquityDKK 17.3m+2,404.3% vs. 2024
Employees19latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Revenue rose 16% (2024 → 2025), to DKK 8.3m.
  • The loss grew: from DKK 13.7m to DKK 13.8m (2024 → 2025).
  • Equity rose 2,404% (2024 → 2025), to DKK 17.3m.

Employees

  • 3 fewer employees than a year earlier: 19 (08/2026) against 22 (08/2025).

Management and owners, last 24 months

  • New in management: Murugasan Claes Nielsen (director, 01/12/2025) and Jesper Møgelvang (director, 23/09/2026).
  • Stepped down: Mette Juhl Jørgensen (board member, 28/04/2026) and Jesper Møgelvang (director, 23/09/2026).
  • New owners registered: Murugasan Claes Nielsen (18/11/2025).
  • No longer registered as owner: Opus Fungus ApS (28/04/2026).

Registrations, last 24 months

  • 18/11/2025: Share capital changed from 1,468,593 DKK to 1,876,093 DKK
  • 07/01/2025: Share capital changed from 1,174,874 DKK to 1,468,593 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 15m−DKK 10m−DKK 5mDKK 0DKK 5mDKK 10mDKK 15mDKK 20m202020212022202320242025
EquityNet profit
Financial figures for BactiQuant A/S
202020212022202320242025Change
Revenue5,4828,35912,38912,3037,1758,319+15.9%
Gross profit3,218−2,955−1,152−756−3,357−2,193+34.7%
Operating profit (EBIT)−1,419−12,679−13,677−10,903−12,643−12,498+1.2%
Profit before tax−1,422−13,434−14,185−13,104−13,723−13,833−0.8%
Net profit−1,113−13,552−14,185−13,104−13,723−13,833−0.8%
Total assets12,52624,51823,17925,50314,69528,068+91%
Equity9,08321,06314,30714,41268917,261+2,404.3%
Liabilities1,7483,4568,87311,09114,00610,808−22.8%
Cash and cash equivalents66810,4423,61911,82485317,868+1,993.6%
Average number of employees71114121112+9.1%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 0DKK 1mDKK 2mDKK 3m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for BactiQuant A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202508/05/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202422/05/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202324/04/2024The companyPDF not statedXBRL
202201/01/2022 – 31/12/202226/04/2023The companyPDF not statedXBRL
202101/01/2021 – 31/12/202127/04/2022The companyPDFXBRL
202001/01/2020 – 31/12/202022/04/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
051015202509/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 2.2mNo. 350 of 421
Better than 17% of the companies in the industry
EquityDKK 17.3mNo. 110 of 431
Better than 75% of the companies in the industry
Number of employees19No. 129 of 431
Better than 70% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,235of 69,742
Better than 1%
No. 6,373of 69,964
Better than 91%
Same industry and fewer than 20 employees329 companies in the comparison
No. 271of 323
Better than 16%
No. 45of 329
Better than 87%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 24,642of 24,791
Better than 1%
No. 4,866of 24,909
Better than 80%
All companies of type A/S18,025 companies in the comparison
No. 17,547of 17,786
Better than 1%
No. 6,697of 18,024
Better than 63%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. BactiQuant A/S−DKK 2.2m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. BactiQuant A/S−DKK 13.8m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. BactiQuant A/SDKK 17.3m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. BactiQuant A/S19
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Mva & Co Holding ApS25%
  • Murugasan Claes Nielsen5%
BactiQuant A/S

Management

6 active registrations

Executive management

Executive management at BactiQuant A/S
NameRoleAppointed
Morten MillerCEO27/07/2022
Henrik Brian Sønderup SørensenDirector07/03/2024
Murugasan Claes NielsenDirector01/12/2025

Board of directors

Board of directors at BactiQuant A/S
NameRoleAppointed
Henrik SkaanderupChair of the board13/03/2019
Søren UlstrupBoard member17/04/2024
Daniel PattersonBoard member17/04/2024
Founders
Morten Miller, Morten Anders Ulsøe Reeslev
Former management (23)
Former management at BactiQuant A/S
NameRoleAppointedResigned
Morten MillerDirector01/07/199931/12/2015
Morten Anders Ulsøe ReeslevDirector01/07/199904/04/2008
Jan Clair NielsenBoard member04/04/200803/05/2017
Morten MillerBoard member04/04/200831/08/2018
Morten Anders Ulsøe ReeslevBoard member04/04/200808/09/2016
Steen Søndergaard-LarsenCEO01/01/201631/08/2018
Morten Anders Ulsøe ReeslevChair of the board09/09/201631/08/2018
Asger Ulsøe ReeslevBoard member03/05/201713/03/2019
Morten MillerChair of the board01/09/201812/03/2019
Morten Anders Ulsøe ReeslevBoard member01/09/201810/11/2020
Morten Anders Ulsøe ReeslevDirector01/09/201817/12/2020
Morten MillerBoard member13/03/201905/04/2022
Leo RasmussenBoard member10/11/202017/04/2024
Morten MillerCEO10/11/202011/08/2021
Claus Vorreiter JensenDirector02/02/202111/08/2021
Henrik Brian Sønderup SørensenDirector01/03/202131/10/2022
Michael Stanley PedersenBoard member15/04/202117/04/2024
Mette Juhl JørgensenBoard member15/04/202128/04/2026
Claus Vorreiter JensenCEO12/08/202127/07/2022
Morten MillerDirector12/08/202126/07/2022
Reto Utiger SørensenDirector01/11/202231/01/2024
Henrik Brian Sønderup SørensenDeputy board member01/03/202406/03/2024
Jesper MøgelvangDirector23/09/202623/09/2026

Signing rule: Selskabet tegnes af en direktør sammen med et bestyrelsesmedlem eller af den samlede bestyrelse.

Address and production units

1 active production units

Blokken 75
3460 Birkerød

Rudersdal Municipality · Postcode 3460

Production units
Production unitAddressEmployeesP number
BactiQuant A/SBlokken 75, 3460 Birkerød191006431176

Purpose

Selskabets formål er at drive virksomhed med fremstilling og salg af mikrobiologiske metoder til måling af mikrobiel kontaminering, og dermed beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

101 registered events
20265 changesmanagement 3 · accounts 1 · ownership 1
  • Jesper Møgelvang appointed director
  • Jesper Møgelvang stepped down as director
  • Annual report for 2025 published
  • Mette Juhl Jørgensen stepped down as board member
  • OPUS FUNGUS ApS is no longer registered as owner
20256 changesmanagement 1 · capital 2 · ownership 1 · accounts 1 · industry 1
  • Murugasan Claes Nielsen appointed director
  • Share capital changed from 1,468,593 DKK to 1,876,093 DKK
  • Murugasan Claes Nielsen registered as owner (5%)
  • Annual report for 2024 published
  • Share capital changed from 1,174,874 DKK to 1,468,593 DKK
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202412 changesownership 3 · accounts 1 · management 8
  • OPUS FUNGUS ApS registered as owner (5%)
  • OPUS FUNGUS ApS is no longer registered as owner
  • SCANELECTRO HOLDING ApS is no longer registered as owner
  • Annual report for 2023 published
  • Daniel Patterson appointed board member
  • Søren Ulstrup appointed board member
  • Michael Stanley Pedersen stepped down as board member
  • Leo Rasmussen stepped down as board member
  • Henrik Brian Sønderup Sørensen appointed director
  • Henrik Brian Sønderup Sørensen stepped down as deputy board member
  • Henrik Brian Sønderup Sørensen appointed deputy board member
  • Reto Utiger Sørensen stepped down as director
20234 changesownership 2 · capital 1 · accounts 1
  • MVA & CO HOLDING ApS registered as owner (25%)
  • MVA & CO HOLDING ApS is no longer registered as owner
  • Share capital changed from 979,062 DKK to 1,174,874 DKK
  • Annual report for 2022 published
20229 changescapital 2 · management 6 · accounts 1
  • Share capital changed from 950,326 DKK to 979,062 DKK
  • Reto Utiger Sørensen appointed director
  • Henrik Brian Sønderup Sørensen stepped down as director
  • Share capital changed from 922,393 DKK to 950,326 DKK
  • Morten Miller appointed ceo
  • Claus Vorreiter Jensen stepped down as ceo
  • Morten Miller stepped down as director
  • Annual report for 2021 published
  • Morten Miller stepped down as board member
202118 changesmanagement 8 · address 1 · accounts 1 · capital 2 · ownership 6
  • Morten Miller appointed director
  • Claus Vorreiter Jensen appointed ceo
  • Claus Vorreiter Jensen stepped down as director
  • Morten Miller stepped down as ceo
  • Moved to Blokken 75, 3460 Birkerød
  • Annual report for 2020 published
  • Michael Stanley Pedersen appointed board member
  • Mette Juhl Jørgensen appointed board member
  • Henrik Brian Sønderup Sørensen appointed director
  • Claus Vorreiter Jensen appointed director
  • Share capital changed from 679,150 DKK to 922,393 DKK
  • MVA & CO HOLDING ApS registered as owner (33.33%)
  • OPUS FUNGUS ApS registered as owner (10%)
  • OPUS FUNGUS ApS is no longer registered as owner
  • MVA & CO HOLDING ApS is no longer registered as owner
  • Share capital changed from 625,000 DKK to 679,150 DKK
  • OPUS FUNGUS ApS registered as owner (20%)
  • OPUS FUNGUS ApS is no longer registered as owner
202012 changesname 1 · management 4 · ownership 5 · capital 1 · merger 1
  • Name changed from MYCOMETER A/S to BactiQuant A/S
  • Morten Anders Ulsøe Reeslev stepped down as director
  • SCANELECTRO HOLDING ApS registered as owner (5%)
  • OPUS FUNGUS ApS registered as owner (25%)
  • MVA & CO HOLDING ApS registered as owner (50%)
  • MVA & CO HOLDING ApS is no longer registered as owner
  • OPUS FUNGUS ApS is no longer registered as owner
  • Morten Miller appointed ceo
  • Leo Rasmussen appointed board member
  • Morten Anders Ulsøe Reeslev stepped down as board member
  • Share capital changed from 542,570 DKK to 625,000 DKK
  • Merger registered in CVR
20195 changescapital 1 · management 4
  • Share capital changed from 567,570 DKK to 542,570 DKK
  • Henrik Skaanderup appointed chair of the board
  • Morten Miller appointed board member
  • Asger Ulsøe Reeslev stepped down as board member
  • Morten Miller stepped down as chair of the board
20186 changesmanagement 6
  • Morten Anders Ulsøe Reeslev appointed board member
  • Morten Anders Ulsøe Reeslev appointed director
  • Morten Miller appointed chair of the board
  • Morten Anders Ulsøe Reeslev stepped down as chair of the board
  • Steen Søndergaard-Larsen stepped down as ceo
  • Morten Miller stepped down as board member
20172 changesmanagement 2
  • Asger Ulsøe Reeslev appointed board member
  • Jan Clair Nielsen stepped down as board member
20164 changescapital 1 · management 3
  • Share capital changed from 525,000 DKK to 567,570 DKK
  • Morten Anders Ulsøe Reeslev appointed chair of the board
  • Morten Anders Ulsøe Reeslev stepped down as board member
  • Steen Søndergaard-Larsen appointed ceo
20151 changemanagement 1
  • Morten Miller stepped down as director
20121 changeaddress 1
  • Moved to Dr Neergaards Vej 3, 2970 Hørsholm
20091 changecapital 1
  • Share capital changed from 500,000 DKK to 525,000 DKK
20089 changesownership 2 · name 1 · capital 1 · management 4 · industry 1
  • MVA & CO HOLDING ApS registered as owner (33.33%)
  • OPUS FUNGUS ApS registered as owner (33.33%)
  • Name changed from MYCOMETER ApS to MYCOMETER A/S
  • Share capital changed from 125,000 DKK to 500,000 DKK
  • Morten Miller appointed board member
  • Morten Anders Ulsøe Reeslev appointed board member
  • Jan Clair Nielsen appointed board member
  • Morten Anders Ulsøe Reeslev stepped down as director
  • Industry changed to Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)
20021 changeaddress 1
  • Moved to Lersø Parkallé 40, 2100 København Ø
20011 changename 1
  • Name changed from MYCOTEC ApS to MYCOMETER ApS
20001 changeindustry 1
  • Industry changed to Forskning og udvikling inden for naturvidenskab og teknik (731000)
19993 changesfounded 1 · management 2
  • Registered as MYCOTEC ApS
  • Morten Anders Ulsøe Reeslev appointed director
  • Morten Miller appointed director

Related companies

Same industry in Rudersdal

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction